
OLMA
Olema Pharmaceuticals Inc.
$5.46
-$0.06(-1.09%)
47
Overall
--
Value
72
Tech
23
Quality
Market Cap
$393.27M
Volume
303.19K
52W Range
$2.86 - $13.93
Target Price
$25.00
Order:
Income Statement
Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|
OPERATING EXPENSES | ||||||
Operating Expenses | $71.5M | $107.0M | $105.0M | $142.3M | ||
Research & Development | $51.1M | $82.3M | $86.1M | $124.5M | ||
Research Expense | $51.1M | $82.3M | $86.1M | $124.5M | ||
Selling, General & Administrative | $20.4M | $24.7M | $18.8M | $17.7M | ||
General & Administrative Expenses | $20.4M | $24.7M | $18.8M | $17.7M | ||
Salaries & Wages | -- | -- | $17.3M | $22.6M | ||
Other Operating Expenses | $1.4M | $1.6M | $1.6M | $1.5M | ||
OPERATING INCOME | ||||||
Operating income | $-71.5M | $-107.0M | $-105.0M | $-142.3M | ||
EBITDA | $-69.4M | $-106.6M | $-101.1M | $-136.5M | ||
NON-OPERATING ITEMS | ||||||
Intinc | $442.0K | $2.2M | $8.3M | $12.7M | ||
Net Non-Operating Interest Income/Expense | $442.0K | $2.2M | $8.3M | $12.7M | ||
Other Income/Expense | $47.0K | $-27.0K | $19.0K | $-102.0K | ||
Other Special Charges | $-47.0K | $-27.0K | $-19.0K | $102.0K | ||
PRE-TAX INCOME | ||||||
EBIT | $-71.1M | $-107.0M | $-102.8M | $-138.0M | ||
Pre-Tax Income | $-71.1M | $-104.8M | $-96.7M | $-129.5M | ||
INCOME TAX | ||||||
Tax Provision | $-25.0K | $-6.7M | $-6.1M | $-8.6M | ||
NET INCOME | ||||||
Net Income | $-71.1M | $-104.8M | $-96.7M | $-129.5M | ||
Net Income (Continuing Operations) | $-71.1M | $-104.8M | $-96.7M | $-129.5M | ||
Net Income (Discontinued Operations) | $-71.1M | $-104.8M | $-96.7M | $-129.5M | ||
Net Income (Common Stockholders) | $-71.1M | $-104.8M | $-96.7M | $-129.5M | ||
Normalized Income | -- | -- | -- | $-138.0M | ||
TOTALS | ||||||
Total Expenses | $71.5M | $107.0M | $105.0M | $142.3M | ||
SHARE & EPS DATA | ||||||
Average Shares Outstanding | $39.5M | $40.0M | $45.2M | $58.7M | ||
Average Shares Outstanding (Diluted) | $39.5M | $40.0M | $45.2M | $58.7M | ||
Shares Outstanding | $40.3M | $40.6M | $55.9M | $68.3M | ||
Basic EPS | $-1.8 | $-2.62 | $-2.14 | $-2.2 | ||
Basic EPS (Continuing Operations) | $-1.8 | $-2.62 | $-2.14 | $-2.2 | ||
Diluted EPS | $-1.8 | $-2.62 | $-2.14 | $-2.2 | ||
Diluted EPS (Continuing Operations) | $-1.8 | $-2.62 | $-2.14 | $-2.2 | ||
OTHER METRICS | ||||||
Other Gand A | $20.4M | $24.7M | $18.8M | $17.7M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | OLMA | $5.46 | -1.1% | 303.19K |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Olema Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW